Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 4 » Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease
Please verify you are not a robot.